Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT01370512

Droxidopa / Pyridostigmine in Orthostatic Hypotension

Conditions: Orthostatic Hypotension

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE2
Enrollment: 30
Sponsor: Mayo Clinic

Location: Mayo Clinic in Rochester Rochester Minnesota

Summary

This study is being done to study the combination of pyridostigmine and low-dose Droxidopa for the treatment of orthostatic hypotension.

Eligibility Criteria

Inclusion Criteria 1. The presence of OH (fall in systolic BP \>=30 mm Hg) is required for this study. 2. Autonomic testing and clinical evaluation demonstrates OH to be of neurogenic etiology. Exclusion Criteria: 1. Pregnant or lactating females. 2. Chronic illnesses or the presence of other conditions that potentially involve the CNS or affect autonomic testing. These include congestive heart failure, recent (\24. 9. History of stroke (diagnosed on clinical grounds as an acute deterioration of neurological function typical of a stroke; confirmatory CT or MRI evidence of stroke will be useful but not necessary). 10. History of electroconvulsive therapy. 11. History of brain surgery for Parkinson's disease.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT01370512). StuddyBuddy aggregates publicly available trial information.